Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas
- PMID: 10728667
Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas
Abstract
Human malignant glioma cell lines express high levels of interleukin-13 receptor (IL-13R). However, the subunit structure of this receptor in primary brain tumor cells is not known. Herein, we examined the subunit composition of IL-13R by analyzing the expression of four different putative subunits of IL-13R complex in 25 primary explants of malignant brain tumors. Reverse transcription-PCR (RT-PCR) of RNA from these tumor cells, normal astrocytes, and normal brain tissue showed that transcripts of IL-13R alpha chain were present in greater abundance in malignant glioma cells compared with normal astrocytes or normal brain tissues. The transcripts for two other chains (e.g., IL-13Ralpha' and IL-4Rbeta), on the other hand, yielded similar PCR positivity in brain tumors as well as in normal samples, whereas transcripts for gammac chain were absent in all brain tumor cells and normal tissues. The specificity of RT-PCR products for these genes was confirmed by oligo liquid hybridization analysis using a radiolabeled sequence-specific internal probe. Indirect immunofluorescence studies for different receptor chains confirmed the RT-PCR results and demonstrated a striking difference in the level of expression of IL-13Ralpha protein between normal astrocytes and malignant astrocytoma cells. These studies establish the IL-13Ralpha subunit as a novel tumor-specific protein that may be useful as a tumor marker, a target for cytotoxin/immunotoxin, or alternatively, a tumor-associated antigen for active, specific immunotherapy.
Comment in
-
Correspondence re: B. H. Joshi et al., interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. Cancer Res., 60: 1168-1172, 2000.Cancer Res. 2001 Jul 15;61(14):5660-2. Cancer Res. 2001. PMID: 11454721 No abstract available.
Similar articles
-
Expression and structure of interleukin 4 receptors in primary meningeal tumors.Cancer. 2005 May 15;103(10):2132-42. doi: 10.1002/cncr.21008. Cancer. 2005. PMID: 15830341
-
Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.Cancer. 2004 Sep 1;101(5):1036-42. doi: 10.1002/cncr.20470. Cancer. 2004. PMID: 15329913
-
Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.Croat Med J. 2003 Aug;44(4):455-62. Croat Med J. 2003. PMID: 12950150
-
An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected link.Crit Rev Oncog. 1998;9(3-4):255-68. Crit Rev Oncog. 1998. PMID: 10201630 Review.
-
Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.J Neurooncol. 2003 Oct;65(1):37-48. doi: 10.1023/a:1026242432647. J Neurooncol. 2003. PMID: 14649884 Review.
Cited by
-
In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice.J Exp Med. 2001 Dec 17;194(12):1743-54. doi: 10.1084/jem.194.12.1743. J Exp Med. 2001. PMID: 11748276 Free PMC article.
-
Clinical development of experimental therapies for malignant glioma.Sultan Qaboos Univ Med J. 2011 Feb;11(1):5-28. Epub 2011 Feb 12. Sultan Qaboos Univ Med J. 2011. PMID: 21509204 Free PMC article.
-
Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer.Int J Oncol. 2022 Jan;60(1):3. doi: 10.3892/ijo.2021.5293. Epub 2021 Dec 16. Int J Oncol. 2022. PMID: 34913066 Free PMC article.
-
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy.Neuro Oncol. 2014 Oct;16(10):1304-12. doi: 10.1093/neuonc/nou045. Epub 2014 Apr 10. Neuro Oncol. 2014. PMID: 24723564 Free PMC article. Review.
-
Interleukin-13 receptor alpha 2-targeted glioblastoma immunotherapy.Biomed Res Int. 2014;2014:952128. doi: 10.1155/2014/952128. Epub 2014 Aug 27. Biomed Res Int. 2014. PMID: 25247196 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical